Synopsis
Synopsis
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-(2-(4-dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol
2. Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (e)-2-butenedioate (2:1) (salt)
3. Ici 204,636
4. Ici 204636
5. Ici-204636
6. Ici204636
7. Quetiapine
8. Seroquel
1. Quetiapine Hemifumarate
2. 111974-72-2
3. Seroquel
4. Ici-204636
5. Seroquel Xr
6. Ici 204,636
7. Quetiapine Fumarate [usan]
8. Zd5077
9. Utapine
10. Zm 204,636
11. Zm 204636
12. Quetiapine (as Fumarate)
13. Quetiapine Hemifumarate Salt
14. 2s3pl1b6uj
15. Quetiapine Fumarate (seroquel)
16. Fk947e
17. Fk-947e
18. Ici 204636
19. Zd-5077
20. Zm-204636
21. Chebi:8708
22. Fk949e
23. (2e)-but-2-enedioic Acid; Bis(2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,9,11,13-heptaen-10-yl}piperazin-1-yl)ethoxy]ethan-1-ol)
24. 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol Fumarate (2:1) (salt)
25. Unii-2s3pl1b6uj
26. Seroquel (tn)
27. 2-(2-(4-dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol
28. Mfcd03423782
29. Quetiapine Fumarate Salt
30. Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-, (2e)-2-butenedioate (2:1)
31. D00458
32. Quetiapine Fumarate Solution
33. 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol Hemifumarate
34. Dsstox_cid_24201
35. Dsstox_rid_80114
36. Dsstox_gsid_44201
37. Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (e)-2-butenedioate (2:1) (salt)
38. Schembl122596
39. Schembl390694
40. Chembl3188993
41. Dtxsid3044201
42. Quetiapine For System Suitability
43. Quetiapine Fumarate [jan]
44. Quetiapine Fumarate (jp17/usp)
45. Hms2089g04
46. Hms3713m10
47. Hms3884a10
48. Quetiapine Fumarate [vandf]
49. Bcp04154
50. Quetiapine Fumarate [mart.]
51. Quetiapine Hemifumarate [mi]
52. Tox21_302366
53. Quetiapine Fumarate [usp-rs]
54. Quetiapine Fumarate [who-dd]
55. S1763
56. Akos015855887
57. Ac-4236
58. Ccg-220464
59. Ks-1099
60. C21h25n3o2s.0.5c4h4o4
61. Ncgc00255945-01
62. Quetiapine Fumarate [orange Book]
63. As-12050
64. Quetiapine Fumarate [ep Monograph]
65. Quetiapine Fumarate [usp Monograph]
66. Cas-111974-72-2
67. Sw220283-1
68. Quetiapine Hemifumarate Salt, >=98% (hplc)
69. 974q697
70. J-002679
71. Q-201653
72. Q27108136
73. Quetiapine Fumarate 1.0 Mg/ml In Methanol (as Free Base)
74. Quetiapine Fumarate, European Pharmacopoeia (ep) Reference Standard
75. 2-[2-(4-dibenzo[b,f][1,4]thiazepin- 11-yl-1-piperazinyl)ethoxy]ethanol Hemifumarate
76. Bis(2-(2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethan-1-ol) Fumarate
77. Quetiapine For System Suitability, European Pharmacopoeia (ep) Reference Standard
78. Quetiapine Fumarate, Pharmaceutical Secondary Standard; Certified Reference Material
79. 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol Fumarate (2:1)
80. Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (e)-2-butenedioate (2:1)
81. Quetiapine Fumarate Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
82. Quetiapine Fumarate, United States Pharmacopeia (usp) Reference Standard, Monograph Mol Wt. 883.09 ((c21h25n3o2s)2 ?? C4h4o4)
Molecular Weight | 883.1 g/mol |
---|---|
Molecular Formula | C46H54N6O8S2 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 14 |
Exact Mass | 882.34445505 g/mol |
Monoisotopic Mass | 882.34445505 g/mol |
Topological Polar Surface Area | 222 Ų |
Heavy Atom Count | 62 |
Formal Charge | 0 |
Complexity | 615 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 6 | |
---|---|
Drug Name | Quetiapine fumarate |
Drug Label | Quetiapine is a psychotropic agent belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is 2-[2-(4-dibenzo [b,f ] [1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-ethanol fumarate (2:1) (salt). It is present in tablets... |
Active Ingredient | Quetiapine fumarate |
Dosage Form | Tablet, extended release; Tablet |
Route | oral; Oral |
Strength | eq 100mg base; 200mg; eq 50mg base; 150mg; eq 150mg base; 400mg; 300mg; eq 200mg base; 50mg; eq 300mg base; eq 400mg base; eq 25mg base |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Apotex; Accord Hlthcare; Alkem Labs; Handa Pharms; Aurobindo Pharma; Torrent Pharms; Lupin; Sandoz; Sun Pharma Global; Roxane; Actavis Grp Ptc; Teva Pharms; Jubilant Generics; Dr Reddys Labs |
2 of 6 | |
---|---|
Drug Name | Seroquel |
PubMed Health | Quetiapine (By mouth) |
Drug Classes | Antipsychotic |
Drug Label | SEROQUEL (quetiapine fumarate) is a psychotropic agent belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is 2-[2-(4-dibenzo [b,f] [1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-ethanol fumarate (2:1) (salt). It... |
Active Ingredient | Quetiapine fumarate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 100mg base; eq 50mg base; eq 200mg base; eq 300mg base; eq 400mg base; eq 25mg base |
Market Status | Prescription |
Company | Astrazeneca |
3 of 6 | |
---|---|
Drug Name | Seroquel xr |
Drug Label | SEROQUEL XR (quetiapine fumarate) is a psychotropic agent belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is 2-[2-(4-dibenzo [b,f ] [1,4] thiazepin-11-yl-1-piperazinyl)ethoxy]-ethanol fumarate (2:1) (salt).... |
Active Ingredient | Quetiapine fumarate |
Dosage Form | Tablet, extended release |
Route | oral; Oral |
Strength | 200mg; eq 50mg base; eq 150mg base; 400mg; 300mg; eq 200mg base; 50mg; eq 300mg base; eq 400mg base |
Market Status | Prescription |
Company | Astrazeneca |
4 of 6 | |
---|---|
Drug Name | Quetiapine fumarate |
Drug Label | Quetiapine is a psychotropic agent belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is 2-[2-(4-dibenzo [b,f ] [1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-ethanol fumarate (2:1) (salt). It is present in tablets... |
Active Ingredient | Quetiapine fumarate |
Dosage Form | Tablet, extended release; Tablet |
Route | oral; Oral |
Strength | eq 100mg base; 200mg; eq 50mg base; 150mg; eq 150mg base; 400mg; 300mg; eq 200mg base; 50mg; eq 300mg base; eq 400mg base; eq 25mg base |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Apotex; Accord Hlthcare; Alkem Labs; Handa Pharms; Aurobindo Pharma; Torrent Pharms; Lupin; Sandoz; Sun Pharma Global; Roxane; Actavis Grp Ptc; Teva Pharms; Jubilant Generics; Dr Reddys Labs |
5 of 6 | |
---|---|
Drug Name | Seroquel |
PubMed Health | Quetiapine (By mouth) |
Drug Classes | Antipsychotic |
Drug Label | SEROQUEL (quetiapine fumarate) is a psychotropic agent belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is 2-[2-(4-dibenzo [b,f] [1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-ethanol fumarate (2:1) (salt). It... |
Active Ingredient | Quetiapine fumarate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 100mg base; eq 50mg base; eq 200mg base; eq 300mg base; eq 400mg base; eq 25mg base |
Market Status | Prescription |
Company | Astrazeneca |
6 of 6 | |
---|---|
Drug Name | Seroquel xr |
Drug Label | SEROQUEL XR (quetiapine fumarate) is a psychotropic agent belonging to a chemical class, the dibenzothiazepine derivatives. The chemical designation is 2-[2-(4-dibenzo [b,f ] [1,4] thiazepin-11-yl-1-piperazinyl)ethoxy]-ethanol fumarate (2:1) (salt).... |
Active Ingredient | Quetiapine fumarate |
Dosage Form | Tablet, extended release |
Route | oral; Oral |
Strength | 200mg; eq 50mg base; eq 150mg base; 400mg; 300mg; eq 200mg base; 50mg; eq 300mg base; eq 400mg base |
Market Status | Prescription |
Company | Astrazeneca |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Antidepressive Agents
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse the...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company : Fermion is fully owned subsidiary of Orion Corporation & headquartered in Espoo, Finland. Together with Orion we are a fully integrated CDMO & offer services covering both APIs & F...
About the Company : Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical indu...
About the Company : Established in 1997, Temad Co. is one of the largest producers of APIs in Iran & an innovative manufacturer of narcotic and non-narcotic products of world-class quality in the Midd...
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
About the Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our...
About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering g...
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
About the Company : Egis is a member of the Servier Group. Egis’ products are manufactured at 3 production sites in Hungary, which are certified by EMA,FDA, ANVISA, PMDA ,KFDA. Egis sells its produc...
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
About the Company : Gonane Pharma, is a contract pharmaceutical company located in Gujarat, India, specializing in the manufacturing and marketing of Corticosteroids, Hormones, Antivirals, and Oncolog...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Quetiapine Hemifumarate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Quetiapine Hemifumarate, including repackagers and relabelers. The FDA regulates Quetiapine Hemifumarate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Quetiapine Hemifumarate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Quetiapine Hemifumarate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Quetiapine Hemifumarate supplier is an individual or a company that provides Quetiapine Hemifumarate active pharmaceutical ingredient (API) or Quetiapine Hemifumarate finished formulations upon request. The Quetiapine Hemifumarate suppliers may include Quetiapine Hemifumarate API manufacturers, exporters, distributors and traders.
click here to find a list of Quetiapine Hemifumarate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Quetiapine Hemifumarate DMF (Drug Master File) is a document detailing the whole manufacturing process of Quetiapine Hemifumarate active pharmaceutical ingredient (API) in detail. Different forms of Quetiapine Hemifumarate DMFs exist exist since differing nations have different regulations, such as Quetiapine Hemifumarate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Quetiapine Hemifumarate DMF submitted to regulatory agencies in the US is known as a USDMF. Quetiapine Hemifumarate USDMF includes data on Quetiapine Hemifumarate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Quetiapine Hemifumarate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Quetiapine Hemifumarate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Quetiapine Hemifumarate Drug Master File in Japan (Quetiapine Hemifumarate JDMF) empowers Quetiapine Hemifumarate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Quetiapine Hemifumarate JDMF during the approval evaluation for pharmaceutical products. At the time of Quetiapine Hemifumarate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Quetiapine Hemifumarate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Quetiapine Hemifumarate Drug Master File in Korea (Quetiapine Hemifumarate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Quetiapine Hemifumarate. The MFDS reviews the Quetiapine Hemifumarate KDMF as part of the drug registration process and uses the information provided in the Quetiapine Hemifumarate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Quetiapine Hemifumarate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Quetiapine Hemifumarate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Quetiapine Hemifumarate suppliers with KDMF on PharmaCompass.
A Quetiapine Hemifumarate CEP of the European Pharmacopoeia monograph is often referred to as a Quetiapine Hemifumarate Certificate of Suitability (COS). The purpose of a Quetiapine Hemifumarate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Quetiapine Hemifumarate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Quetiapine Hemifumarate to their clients by showing that a Quetiapine Hemifumarate CEP has been issued for it. The manufacturer submits a Quetiapine Hemifumarate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Quetiapine Hemifumarate CEP holder for the record. Additionally, the data presented in the Quetiapine Hemifumarate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Quetiapine Hemifumarate DMF.
A Quetiapine Hemifumarate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Quetiapine Hemifumarate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Quetiapine Hemifumarate suppliers with CEP (COS) on PharmaCompass.
A Quetiapine Hemifumarate written confirmation (Quetiapine Hemifumarate WC) is an official document issued by a regulatory agency to a Quetiapine Hemifumarate manufacturer, verifying that the manufacturing facility of a Quetiapine Hemifumarate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Quetiapine Hemifumarate APIs or Quetiapine Hemifumarate finished pharmaceutical products to another nation, regulatory agencies frequently require a Quetiapine Hemifumarate WC (written confirmation) as part of the regulatory process.
click here to find a list of Quetiapine Hemifumarate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Quetiapine Hemifumarate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Quetiapine Hemifumarate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Quetiapine Hemifumarate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Quetiapine Hemifumarate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Quetiapine Hemifumarate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Quetiapine Hemifumarate suppliers with NDC on PharmaCompass.
Quetiapine Hemifumarate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Quetiapine Hemifumarate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Quetiapine Hemifumarate GMP manufacturer or Quetiapine Hemifumarate GMP API supplier for your needs.
A Quetiapine Hemifumarate CoA (Certificate of Analysis) is a formal document that attests to Quetiapine Hemifumarate's compliance with Quetiapine Hemifumarate specifications and serves as a tool for batch-level quality control.
Quetiapine Hemifumarate CoA mostly includes findings from lab analyses of a specific batch. For each Quetiapine Hemifumarate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Quetiapine Hemifumarate may be tested according to a variety of international standards, such as European Pharmacopoeia (Quetiapine Hemifumarate EP), Quetiapine Hemifumarate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Quetiapine Hemifumarate USP).
LOOKING FOR A SUPPLIER?